# A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State

> **NCT01706796** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06273340
- **DRUG:** PF-06273340
- **DRUG:** PF-06273340
- **DRUG:** PF-06273340
- **DRUG:** PF-06273340
- **DRUG:** PF-06273340

## Key facts

- **NCT ID:** NCT01706796
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01706796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01706796, "A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01706796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*